Patent details

EP1789084 Title: DECREASING POTENTIAL IATROGENIC RISKS ASSOCIATED WITH INFLUENZA VACCINES

Basic Information

Publication number:
EP1789084
PCT Application Number:
PCT/IB/2005/003266
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057950123
PCT Publication Number:
WO/2006/027698
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DECREASING POTENTIAL IATROGENIC RISKS ASSOCIATED WITH INFLUENZA VACCINES
French Title of Invention:
REDUCTION DE RISQUES IATROGENES POTENTIELS ASSOCIES AUX VACCINS CONTRE LA GRIPPE
German Title of Invention:
VERMINDERUNG VON POTENTIELLEN IATROGENEN RISIKEN IN VERBINDUNG MIT INFLUENZA IMPFSTOFFEN
SPC Number:

Dates

Filing date:
09/09/2005
Grant date:
17/11/2010
EP Publication Date:
17/11/2010
PCT Publication Date:
16/03/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/05/2007
EP B1 Publication Date:
17/11/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/09/2014
Expiration date:
09/09/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/09/2005
 
 

Name:
Novartis Vaccines and Diagnostics GmbH
Address:
Emil-von-Behring-Strasse 76, 35041 Marburg, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
01/12/2010
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
GREGERSEN Jens-Peter, Chiron Behring GmbH & Co.
Address:
Germany (DE)

Priority

Priority Number:
04255471
Priority Date:
09/09/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 39/145;
Filing date Document type Number of pages